Research Library
Peptide Research, Explained
Evergreen guides on purity, documentation, handling, and the compounds themselves — written as research and procurement education. For laboratory research use only.
GHK-Cu vs. Matrixyl 3000: A Research Comparison
A copper tripeptide complex and a palmitoylated peptide blend share a sequence but not a structure. What differs and what to check.
Read article →
PT-141 vs. Melanotan II: A Research Comparison
Two cyclic melanocortin peptides that differ by one end group. What separates them and what a certificate should confirm.
Read article →
AOD-9604 vs. HGH Fragment 176-191: A Research Comparison
Two close relatives from the C-terminus of growth hormone, separated by one residue. What differs and what a certificate should confirm.
Read article →
Cagrilintide vs. Tirzepatide: A Research Comparison
An amylin analog and a dual GIP/GLP-1 agonist are not the same tool. A structural and analytical comparison for research buyers.
Read article →
CJC-1295 vs. Sermorelin: A Research Comparison
Both are 29-residue GHRH analogs, but they are not the same peptide. A structural and analytical comparison for research buyers.
Read article →
TB-500 vs. Thymosin Beta-4: What Is Actually the Difference?
TB-500 is a supplier label, thymosin beta-4 is a 43-residue protein. Here is how they differ and what a certificate should confirm.
Read article →
GHK-Cu vs Other Copper Peptides: GHK, AHK-Cu and Salts Compared
Explains how GHK-Cu differs from free GHK, AHK-Cu, palmitoylated derivatives and simple copper salts, and what to check on a certificate.
Read article →
CJC-1295 + Ipamorelin Blend vs Separate Vials: Research Design Guide
Compares a fixed CJC-1295 + ipamorelin blend with two single vials on ratio control, analytical paperwork, stability, record keeping and cost.
Read article →
GLOW Stack vs Individual Peptides: Blend or Separate Vials?
A blend or separate vials? How fixed ratios, per-component COAs and shared stability affect research design.
Read article →
Tesamorelin vs Sermorelin: Differences in Research
Both are GHRH analogs, but sermorelin is the 29-residue fragment and tesamorelin is the full 44-mer with an N-terminal hexenoyl cap. This article compares structure, stability, handling and COA expectations for laboratory research.
Read article →
KPV vs. Other Research Peptides: A Mechanistic Comparison
How KPV compares to BPC-157, TB-500, GHK-Cu, and Selank across mechanism of action, research applications, and structural properties — a guide to picking the right research tool.
Read article →
MOTS-c vs. Other Mitochondrial-Derived Peptides: A Research Comparison
How MOTS-c compares to Humanin and the SHLP peptides across mechanism, research focus, and structural properties — a guide for researchers choosing between mitochondrial-derived peptides.
Read article →
Semaglutide vs. Tirzepatide: Brand Chemistry Comparison
A chemistry and receptor-pharmacology comparison of semaglutide and tirzepatide for laboratory researchers, with brand context and analytical differentiation.
Read article →
KPV vs Alpha-MSH: Melanocortin Pathway Research Comparison
A careful comparison of KPV and its parent alpha-MSH: size, receptor pharmacology, PepT1 transport, research applications and study-design implications.
Read article →
Selank vs. Semax: Research Peptide Comparison
Selank (tuftsin-derived) and Semax (ACTH-derived) are often grouped but differ in origin, mechanism and research focus. A side-by-side comparison.
Read article →
Sermorelin vs Ipamorelin: Comparing Two GH Research Pathways
A careful comparison of sermorelin (GHRHR) and ipamorelin (GHS-R1a): signaling, selectivity, kinetics, somatostatin sensitivity and which fits which research question.
Read article →
Semaglutide vs. Tirzepatide vs. Retatrutide vs. Cagrilintide: 2026 GLP-1 Research Comparison
A side-by-side research comparison of the four most-studied GLP-1-class research peptides — semaglutide, tirzepatide, retatrutide, and cagrilintide — covering receptor targets, mechanism, and how each fits into a laboratory research program.
Read article →
CagriSema Combination Research: Cagrilintide and Semaglutide Co-Agonism
A research-focused look at CagriSema, the fixed-ratio cagrilintide + semaglutide combination studied in Novo Nordisk's REDEFINE program, including receptor biology, preclinical rationale, and how it compares to single-agent GLP-1 research.
Read article →
Semaglutide and Tirzepatide: A Research Buyer's Guide
A research buyer's guide to semaglutide and tirzepatide: brand names vs. research compounds, structural differences, verification checks and handling.
Read article →
NAD+ vs. NMN vs. NR (Research Comparison)
A careful research comparison of NAD+, NMN and NR: where each sits in the pathway, how each enters cells, and how to design and verify experiments.
Read article →
Cagrilintide vs. Pramlintide (Research Comparison)
A careful comparison of two amylin analogs: how pramlintide fixed aggregation, how cagrilintide added duration, and what that means for assay design and verification.
Read article →
Best Research Peptide Stacks 2026: Combination Rationale, Coverage, and Comparison
A researcher's guide to the most-studied multi-peptide research combinations in 2026 — the mechanistic logic behind stacking, and how the leading combinations (GH-axis, tissue repair, dermal, metabolic) compare.
Read article →
CJC-1295 vs. Ipamorelin: A Research Comparison
A careful comparison of CJC-1295 (no DAC) and ipamorelin: receptors, structures, analytical differences and when singles or the blend fit a research question.
Read article →
BPC-157 vs. TB-500: A Research Comparison
A careful comparison of BPC-157 and TB-500: different origins and mechanisms, overlapping research endpoints, verification differences, and how to design studies with each.
Read article →25 articles in Comparison